Swedish's Dr. James Porter, one of the country's foremost robotic surgery experts, has treated over 5,000 patients with urologic cancer using da Vinci surgical robot.

Late-stage diagnoses have risen and a decline in deaths has stalled.

Prostate cancer is the second-most common cancer among men in the U.S., affecting 13 out of every 100 American men over the course of their lifetime.

Dr. James Porter, medical director for robotic surgery at Swedish First Hill, received this year's Menon Award, which is presented annually at the North American Robotic Urology Symposium.

Innovative technology improves visualization of patient anatomy, study finds.